{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2,4-Dinitrochlorobenzene", "Atopic dermatitis", "Interleukin 4", "Skin barrier function", "Stechamone", "Stellera chamaejasme L."]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29653408", "DateCompleted": {"Year": "2018", "Month": "10", "Day": "03"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "04", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1016/j.intimp.2018.04.008", "S1567-5769(18)30152-8"], "Journal": {"ISSN": "1878-1705", "JournalIssue": {"Volume": "59", "PubDate": {"Year": "2018", "Month": "Jun"}}, "Title": "International immunopharmacology", "ISOAbbreviation": "Int Immunopharmacol"}, "ArticleTitle": "A new flavonoid from Stellera chamaejasme L., stechamone, alleviated 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in a murine model.", "Pagination": {"StartPage": "113", "EndPage": "119", "MedlinePgn": "113-119"}, "Abstract": {"AbstractText": ["Stellera chamaejasme L. (family Thymelaeaceae), also known as 'Langdu', has been traditionally used to treat of skin-related diseases, such as, psoriasis and skin ulcers. The aim of this study was to identify the biologically active component of S. chamaejasme and evaluate its preventive effects on IL-4 and mast cell degranulation in RBL-2H3 cells and on the development of atopic dermatitis (AD) in 2,4-dinitrochlorobenzene (DNCB)-treated SKH-1 hairless mice. A novel flavonoid, genkwanin 5-O-xylosyl(1\u202f\u2192\u202f2)glucoside (named stechamone), and three known compounds (umbelliferone, luteolin, and luteolin-7-O-glucoside) were isolated from the aerial parts of S. chamaejasme using chromatographic methods. Of these four compounds, stechamone most potently inhibited IL-4 production and mast cell degranulation in RBL-2H3 cells. Topical application of 0.5% stechamone improved atopic skin symptoms, including, erythema (redness), pruritus (itching), exudation (weeping), excoriation (peeling), and lichenification (skin thickening) in DNCB-treated AD mice by accelerating skin barrier recovery function and suppressing inflammatory cell infiltration. In addition, stechamone attenuated DNCB-induced increases in IL-4 (an inflammatory T<sub>H</sub>2 cytokine) expression and in serum IgE levels in our murine model of AD. DNCB induced AD-like skin lesions, but treatment with stechamone exhibited strong anti-atopic activity by regulating skin barrier function and reducing inflammatory responses. The results obtained suggest stechamone is a potential anti-atopic agent and treatment for skin inflammatory diseases."], "CopyrightInformation": "Copyright \u00a9 2018 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea."}], "LastName": "Jo", "ForeName": "Beom-Geun", "Initials": "BG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea."}], "LastName": "Park", "ForeName": "No-June", "Initials": "NJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea."}], "LastName": "Jegal", "ForeName": "Jonghwan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea."}], "LastName": "Choi", "ForeName": "Sangho", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea."}], "LastName": "Lee", "ForeName": "Sang Woo", "Initials": "SW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plants, Yunnan Academy of Agricultural Sciences, Yunnan 650205, China."}], "LastName": "Jin", "ForeName": "Hang", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea. Electronic address: snkim@kist.re.kr."}], "LastName": "Kim", "ForeName": "Su-Nam", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea. Electronic address: mhyang@pusan.ac.kr."}], "LastName": "Yang", "ForeName": "Min Hye", "Initials": "MH"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Int Immunopharmacol", "NlmUniqueID": "100965259", "ISSNLinking": "1567-5769"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Allergic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Dinitrochlorobenzene"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "37341-29-0", "NameOfSubstance": "Immunoglobulin E"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Allergic Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["blood", "chemically induced", "drug therapy"], "DescriptorName": "Dermatitis, Atopic"}, {"QualifierName": [], "DescriptorName": "Dinitrochlorobenzene"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin E"}, {"QualifierName": ["blood", "genetics"], "DescriptorName": "Interleukin-4"}, {"QualifierName": [], "DescriptorName": "Mice, Hairless"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Skin"}, {"QualifierName": [], "DescriptorName": "Thymelaeaceae"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "2", "Day": "18"}, {"Year": "2018", "Month": "4", "Day": "5"}, {"Year": "2018", "Month": "4", "Day": "5"}, {"Year": "2018", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29653408", "10.1016/j.intimp.2018.04.008", "S1567-5769(18)30152-8"]}}]}